News
Clinical Topics
Integrative Care
Global Bulletin
All News
Approval Alert
Media
2 Minute Drill
Around the Practice
Between the Lines
Clinical Consult
Expert Interviews
Face Off
Medical World News
Morning Rounds
OncView
Podcasts
Readout 360
Satellite Sessions
Sponsored Media
Training Academy
Year in Review
Conferences
Publications
All Journals
For Authors
Tumor Board
Events
Frontline Forum
CME/CE
Resources
Contemporary Concepts
Awareness Month
Interactive Tools
Nurse Practitioners/Physician's Assistants
Partners
Sponsored
Subscribe
Print Subscription
eNewsletter

logo
Spotlight
Around the Practice
Between the Lines
Contemporary Concepts
Journal
OncView
Podcasts
Readout 360
2022 ASCO Genitourinary Cancers Symposium Urothelial Cancer Updates
CancerNetwork® Inaugural Face-Off
Contemporary Concepts in Hematologic Oncology
Insights from Experts at Mayo Clinic on Translating Evidence to Clinical Practice
Optimizing Outcomes in Patients with HER2+ Metastatic Breast Cancer
Clinical
Acute Myeloid Leukemia
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer
Clinical Topics
Integrative Care
Global Bulletin
All News
Approval Alert
2 Minute Drill
Around the Practice
Between the Lines
Clinical Consult
Expert Interviews
Face Off
Medical World News
Morning Rounds
OncView
Podcasts
Readout 360
Satellite Sessions
Sponsored Media
Training Academy
Year in Review
Conferences
All Journals
For Authors
Tumor Board
Frontline Forum
CME/CE
Contemporary Concepts
Awareness Month
Interactive Tools
Nurse Practitioners/Physician's Assistants
Partners
Sponsored
Print Subscription
eNewsletter
Advertisement
Breast Cancer
| Kidney Cancer
| Leukemia
| Lymphoma
| Multiple Myeloma
| Non-Small Cell Lung Cancer (NSCLC)
| Small Cell Lung Cancer (SCLC)
| Adverse Effects
| Biomarkers
| Bladder Cancer
| Brain Cancer
| Cervical Cancer
| Colorectal Cancer
| Endometrial Cancer
| Esophageal Cancer
| Gastrointestinal Cancer
| Genitourinary Cancers
| Gynecologic Cancers
| Head & Neck Cancer
| Hematology
| Hormone-related Cancers
| Immunotherapy
| Infection
| Liver Cancer
| Lung Cancer
| Mesothelioma
| Neuroendocrine Tumors
| Oncology
| Ovarian Cancer
| Ovarian Cancer Clincal Consult
| Pancreatic Cancer
| Pediatric Cancers
| Prostate Cancer
| Radiation Oncology
| Sarcoma
| Screening
| Skin Cancer & Melanoma
| Surgery
| Thoracic Malignancies
| Thyroid Cancer
View All >>
  • Adverse Effects
  • Biomarkers
  • Bladder Cancer
  • Brain Cancer
  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Endometrial Cancer
  • Esophageal Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Hematology
  • Hormone-related Cancers
  • Immunotherapy
  • Infection
  • Kidney Cancer
  • Leukemia
  • Liver Cancer
  • Lung Cancer
  • Lymphoma
  • Mesothelioma
  • Multiple Myeloma
  • Neuroendocrine Tumors
  • Non-Small Cell Lung Cancer (NSCLC)
  • Oncology
  • Ovarian Cancer
  • Ovarian Cancer Clincal Consult
  • Pancreatic Cancer
  • Pediatric Cancers
  • Prostate Cancer
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Small Cell Lung Cancer (SCLC)
  • Surgery
  • Thoracic Malignancies
  • Thyroid Cancer

SPOTLIGHT -

Around the Practice
| Between the Lines
| Contemporary Concepts
| Journal
| OncView
| Podcasts
| Readout 360
| 2022 ASCO Genitourinary Cancers Symposium Urothelial Cancer Updates
| CancerNetwork® Inaugural Face-Off
| Contemporary Concepts in Hematologic Oncology
| Insights from Experts at Mayo Clinic on Translating Evidence to Clinical Practice
| Optimizing Outcomes in Patients with HER2+ Metastatic Breast Cancer

Best use yet for electronic toys: Easing treatment-related pain for children with cancer

May 5, 2010
Lois Wingerson

Most of the youngest Americans have viewed IPods and video games as essentials for many years. Yet their use to distract kids with cancer from their pain is still in beta testing.

For a child with cancer, an introduction to the pediatric oncology unit usually entails undergoing many procedures in quick succession. One study has shown that for these children pain associated with interventions is twice as common as the pain from the disease itself. Just as for adults who have cancer, experiencing pain is one of their greatest fears.

All of this being the case, you'd think medical science would have an intense focus on alleviating procedure-related pain in pediatric oncology, using the best tools at our disposal. But while children with cancer may play on their Wii after they get home, so far there's little solid evidence for the effectiveness of virtual reality or even ordinary video games to distract them during treatment.

Children's hospitals are using them nonetheless. At the cancer clinic in Texas Children's Hospital (a leader in exploring pain management techniques), among other strategies such as live performers, positioning for comfort, and medication, children have the benefit of hand-held video games to distract them from pain and anxiety, says child life specialist Breanna Hopkins. The clinic is in the process of installing Wii systems as well.

As electronic toys are booming in variety and popularity, only now has a randomized study evaluated the simple procedure of letting children listen to an iPod (as I myself always do at the dentist) before and during lumbar puncture for leukemia, and then asking them about the experience afterwards.

The study appears this month in the Journal of Pediatric Oncology Nursing.

Two years ago, a Cochrane Collaboration systematic review determined that only 3 kinds of noninvasive interventions have shown promise for reducing children's pain associated with procedures that involve needles: cognitive behavior therapy, hypnosis, and "distraction." The first two interventions (as well as the invasive kind) require considerable time, effort, and training for medical personnel. Use of an iPod, in contrast, is something about which an American child might actually instruct an oncologist.

Oncology nurse Than Nahn Nguyen of the National Hospital of Pediatrics in Hanoi approached Stefan Nilsson of Sweden to collaborate, because of his prior research testing "music medicine" and virtual reality for cancer-related pain in children. The Hanoi study involved 40 children with leukemia who had all had lumbar puncture previously.

This time, they got no other form of pain relief than music-if that. All were given headphones, but only half were randomized (by choosing a slip of paper) to hear music through them. The lucky half were given iPods and shown how to use them, selecting their own playlist. The music began 10 minutes before the procedure did. Afterwards, 20 were interviewed with open-ended questions.

Those in the iPod group scored significantly lower for pain, heart rate, respiratory rate, and anxiety. Some said afterwards that they didn't even notice when the injection began. Both groups wanted to hear music the next time around.

“I didn’t feel any pain," said one child in the iPod group, adding with a smile: "The last time, I had to hold my mother’s hand very tightly…I didn’t need to do that this time." Children in the control group called the procedure "very painful" and spoke of anxiety, a sense of chaos, and fear of death.
Music has a venerable record as a form of distraction. There's less experience with using virtual reality, which involves many technical issues and can be quite complicated.

Nilsson, who is a pain management nurse at The Queen Silvia Children's Hospital in Goteborg, has tested a 3D virtual reality game involving a hunt for diamonds in an amusement park, experienced via headset and remote control. The team created it from off-the-shelf software and tested it in a randomized controlled trial involving 42 children and adolescents with cancer, before and during  venous punctures or the installation of subcutaneous venous ports.

The subjects in this study did not get to choose their own entertainment, which may be a problem: Some of them (especially boys) called the game "corny," although most would choose to play it again because they all found it "distracting." There was no significant difference between the groups in self-reported measures of pain, although nurses scoring an objective scale noticed fewer visual or motor signals of pain during venipuncture. The researchers note that none of the subjects experienced intense pain; all had also received cold spray or lidocaine and prilocaine before the procedure.

Perhaps a more useful result from the study reported in European Journal of Oncology Nursing was that most subjects neither noticed nor cared about the 3D component. This could dispense with the headset. Something on a flat computer screen could be just as effective, especially if the patient could choose the game. In fact, any game a kid enjoys might work, as long as it doesn't involve much arm movement. This all needs to be tested further, of course.

Nilsson says he hasn't "yet" approached game manufacturers about further research or perhaps about donating video games to pediatric oncology units, but he's attracted to the idea. Short of that, even in the current economy, the outright purchase of a few iPods and a few dozen tracks might not be out of the question for a cancer hospital.

One might hazard a guess that the young patients would approve. During the post-procedure interview, one child in the Hanoi study asked about the next procedure. "Will I be able to listen to music, or not?"

Related Videos
young person with cancer
uterus
Related Content

Therapy Reduction May Not Affect Survival in Pediatric Neuroblastoma

May 29th 2023

Proton Therapy May Improve Cognitive Outcomes in Craniopharyngioma

May 18th 2023

Early Data Support GD2-Targeting CAR T in Pediatric High-Risk Neuroblastoma

May 9th 2023

B-ALL Hispanic Population Underrepresented in Hospital CAR T Referrals

April 13th 2023

EU's CHMP Recommends Injection Against Pediatric Chemo-Induced Ototoxicity

April 9th 2023

Models May Predict Late Kidney Failure in Pediatric Cancer Survivors

March 22nd 2023

Therapy Reduction May Not Affect Survival in Pediatric Neuroblastoma

May 29th 2023

Proton Therapy May Improve Cognitive Outcomes in Craniopharyngioma

May 18th 2023

Early Data Support GD2-Targeting CAR T in Pediatric High-Risk Neuroblastoma

May 9th 2023

B-ALL Hispanic Population Underrepresented in Hospital CAR T Referrals

April 13th 2023

EU's CHMP Recommends Injection Against Pediatric Chemo-Induced Ototoxicity

April 9th 2023

Models May Predict Late Kidney Failure in Pediatric Cancer Survivors

March 22nd 2023

Therapy Reduction May Not Affect Survival in Pediatric Neuroblastoma

May 29th 2023

Proton Therapy May Improve Cognitive Outcomes in Craniopharyngioma

May 18th 2023

Early Data Support GD2-Targeting CAR T in Pediatric High-Risk Neuroblastoma

May 9th 2023

B-ALL Hispanic Population Underrepresented in Hospital CAR T Referrals

April 13th 2023

EU's CHMP Recommends Injection Against Pediatric Chemo-Induced Ototoxicity

April 9th 2023

Models May Predict Late Kidney Failure in Pediatric Cancer Survivors

March 22nd 2023
Related Content

Patients under the age of 3 with neuroblastoma experienced no significant negative impact on survival when their disease was reclassified from high-risk to intermediate-risk and their therapy was thusly reduced.

Therapy Reduction May Not Affect Survival in Pediatric Neuroblastoma

May 29th 2023
Article

Patients under the age of 3 with neuroblastoma experienced no significant negative impact on survival when their disease was reclassified from high-risk to intermediate-risk and their therapy was thusly reduced.


Proton Therapy May Improve Cognitive Outcomes in Craniopharyngioma | Image Credit: © Dr_Microbe - stock.adobe.com.

Proton Therapy May Improve Cognitive Outcomes in Craniopharyngioma

May 18th 2023
Article

A phase 2 trial indicates that limited surgery and post-operative proton therapy result in a high rate of tumor control and less severe complications in young patients with craniopharyngioma.


Early Data Support GD2-Targeting CAR T in Pediatric High-Risk Neuroblastoma | Image Credit: © crevis - stock.adobe.com.

Early Data Support GD2-Targeting CAR T in Pediatric High-Risk Neuroblastoma

May 9th 2023
Article

Investigators of a phase 1/2 trial report that CAR T cells targeting disialoganglioside GD2 may result in long-lasting antitumor activity in young patients with high-risk neuroblastoma.


Investigators highlight the importance of building partnerships between CAR T-cell centers and external hospitals to increase treatment referrals and access to clinical trials for patients with B-cell acute lymphoblastic leukemia.

B-ALL Hispanic Population Underrepresented in Hospital CAR T Referrals

April 13th 2023
Article

Investigators highlight the importance of building partnerships between CAR T-cell centers and external hospitals to increase treatment referrals and access to clinical trials for patients with B-cell acute lymphoblastic leukemia.


EU's CHMP Recommends Injection Against Pediatric Chemo-Induced Ototoxicity  | Image Credit: VanHope - stock.adobe.com.

EU's CHMP Recommends Injection Against Pediatric Chemo-Induced Ototoxicity

April 9th 2023
Article

Findings from 2 phase 3 trials support the recommendation to approve sodium thiosulfate to reduce the risk of cisplatin-related hearing loss in pediatric patients with solid tumors in Europe.


Findings from a cohort of the Childhood Cancer Survivor Study identify a prediction model that may accurately identify childhood cancer survivors at varying risks of late kidney failure.

Models May Predict Late Kidney Failure in Pediatric Cancer Survivors

March 22nd 2023
Article

Findings from a cohort of the Childhood Cancer Survivor Study identify a prediction model that may accurately identify childhood cancer survivors at varying risks of late kidney failure.

About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.